CLINICAL_TRIALS
trial_result
· 2025-03-07
Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis [Phase 3]
Summary
A Phase 3 trial evaluating the safety and efficacy of upadacitinib for giant cell arteritis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AbbVie | Conditions: Giant Cell Arteritis (GCA) | Phase 3 | Status: COMPLETED | Results posted: 2025-03-07